Seeing Is Believing
XERS is currently covered by 3 analysts with an average price target of $7.53. This is a potential upside of $3.8 (101.88%) from yesterday's end of day stock price of $3.73.
Xeris Pharmaceuticals's activity chart (see below) currently has 23 price targets and 26 ratings on display. The stock rating distribution of XERS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.96% with an average time for these price targets to be met of 19.83 days.
Highest price target for XERS is $6.6, Lowest price target is $3, average price target is $7.53.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 16-Jul-2018.
Currently out of the existing stock ratings of XERS, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6.6
$3.32 (101.22%)
$6
25 days ago
(11-Nov-2024)
0/11 (0%)
$3.29 (99.40%)
Buy
$3
$-0.28 (-8.54%)
$3
25 days ago
(11-Nov-2024)
2/3 (66.67%)
$-0.31 (-9.37%)
81
Buy
$4.5
$2.06 (84.43%)
$6.5
1 years 3 months 8 days ago
(28-Aug-2023)
0/2 (0%)
$2.23 (98.24%)
Buy
$6
$2.72 (82.93%)
2 years 8 months 20 days ago
(16-Mar-2022)
0/1 (0%)
$3.21 (115.05%)
Buy
$8
$4.72 (143.90%)
$9
3 years 4 months ago
(06-Aug-2021)
1/9 (11.11%)
$5.69 (246.32%)
38
What is XERS (Xeris Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on XERS (Xeris Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most bullish on XERS (Xeris Pharmaceuticals)?
Which analyst is the currently most reserved on XERS (Xeris Pharmaceuticals)?